Brief: Bellus Health Completes Patient Enrollment In SOOTHE Phase 2b Trial For Refractory Chronic Cough
23/09/2021 12:15
Sept 23 (Reuters) - BELLUS Health Inc BLU.TO :
* BELLUS HEALTH ANNOUNCES COMPLETION OF PATIENT ENROLLMENT
IN
SOOTHE PHASE 2B TRIAL FOR REFRACTORY CHRONIC COUGH AND BLUEPRINT
PHASE 2A TRIAL FOR CHRONIC PRURITUS ASSOCIATED WITH ATOPIC
DERMATITIS
* BELLUS HEALTH INC - TOPLINE RESULTS FROM BOTH STUDIES ARE
EXPECTED IN DECEMBER 2021
Source text for Eikon: ID:nBwby4Vha
Further company coverage: BLU.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BELLUS Health
See all newsBrief: Bellus Health Inc. Calls Special Shareholders’ Meeting In Connection With Gsk Acquisition
Brief: Bellus Health Reports First Quarter 2023 Financial Results And Business Highlights
Press Digest: British Business - April 19
Canada Stocks: Toronto market extends winning streak on 'soft landing' hopes
Bellus soars as GSK plans to buy drug developer for $2 bln